BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 36833249)

  • 1. A Founder Intronic Variant in
    Kantaputra PN; Angkurawaranon S; Intachai W; Ngamphiw C; Olsen B; Tongsima S; Cox TC; Ketudat Cairns JR
    Genes (Basel); 2023 Jan; 14(2):. PubMed ID: 36833249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic Variation in Vietnamese Osteogenesis Imperfecta Patients Sharing a Recessive
    Zhytnik L; Duy BH; Eekhoff M; Wisse L; Pals G; Reimann E; Kõks S; Märtson A; Maugeri A; Maasalu K; Micha D
    Genes (Basel); 2022 Feb; 13(3):. PubMed ID: 35327962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel P3H1 mutation is associated with osteogenesis imperfecta type VIII and dental anomalies.
    Kantaputra PN; Dejkhamron P; Intachai W; Ngamphiw C; Ketudat Cairns JR; Kawasaki K; Ohazama A; Olsen B; Tongsima S; Angkurawaranon S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Dec; 132(6):e198-e207. PubMed ID: 33737016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe cases of osteogenesis imperfecta type VIII due to a homozygous mutation in P3H1 (LEPRE1) and review of the literature.
    Bala MM; Bala KA
    Adv Clin Exp Med; 2021 Dec; 30(12):1233-1238. PubMed ID: 34637196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new case of osteogenesis imperfecta type VIII and retinal detachment.
    de Souza LT; Nunes RR; de Azevedo Magalhães O; Maria Félix T
    Am J Med Genet A; 2021 Jan; 185(1):238-241. PubMed ID: 33098264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recessive osteogenesis imperfecta caused by LEPRE1 mutations: clinical documentation and identification of the splice form responsible for prolyl 3-hydroxylation.
    Willaert A; Malfait F; Symoens S; Gevaert K; Kayserili H; Megarbane A; Mortier G; Leroy JG; Coucke PJ; De Paepe A
    J Med Genet; 2009 Apr; 46(4):233-41. PubMed ID: 19088120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milder presentation of osteogenesis imperfecta type VIII due to compound heterozygosity for a predicted loss-of-function variant and novel missense variant in
    Mikhail KA; VanSickle E; Rossetti LZ
    Cold Spring Harb Mol Case Stud; 2023 Feb; 9(1):. PubMed ID: 36963805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted exome sequencing identifies novel compound heterozygous mutations in P3H1 in a fetus with osteogenesis imperfecta type VIII.
    Huang Y; Mei L; Lv W; Li H; Zhang R; Pan Q; Tan H; Guo J; Luo X; Chen C; Liang D; Wu L
    Clin Chim Acta; 2017 Jan; 464():170-175. PubMed ID: 27864101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolyl 3-hydroxylase 1 and CRTAP are mutually stabilizing in the endoplasmic reticulum collagen prolyl 3-hydroxylation complex.
    Chang W; Barnes AM; Cabral WA; Bodurtha JN; Marini JC
    Hum Mol Genet; 2010 Jan; 19(2):223-34. PubMed ID: 19846465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crtap and p3h1 knock out zebrafish support defective collagen chaperoning as the cause of their osteogenesis imperfecta phenotype.
    Tonelli F; Cotti S; Leoni L; Besio R; Gioia R; Marchese L; Giorgetti S; Villani S; Gistelinck C; Wagener R; Kobbe B; Fiedler IAK; Larionova D; Busse B; Eyre D; Rossi A; Witten PE; Forlino A
    Matrix Biol; 2020 Aug; 90():40-60. PubMed ID: 32173581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta.
    Marini JC; Cabral WA; Barnes AM
    Cell Tissue Res; 2010 Jan; 339(1):59-70. PubMed ID: 19862557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of collagen prolyl 3-hydroxylation on skeletal tissues.
    Homan EP; Lietman C; Grafe I; Lennington J; Morello R; Napierala D; Jiang MM; Munivez EM; Dawson B; Bertin TK; Chen Y; Lua R; Lichtarge O; Hicks J; Weis MA; Eyre D; Lee BH
    PLoS Genet; 2014 Jan; 10(1):e1004121. PubMed ID: 24465224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants.
    Tüysüz B; Elkanova L; Uludağ Alkaya D; Güleç Ç; Toksoy G; Güneş N; Yazan H; Bayhan AI; Yıldırım T; Yeşil G; Uyguner ZO
    Bone; 2022 Feb; 155():116293. PubMed ID: 34902613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PPIB mutations cause severe osteogenesis imperfecta.
    van Dijk FS; Nesbitt IM; Zwikstra EH; Nikkels PG; Piersma SR; Fratantoni SA; Jimenez CR; Huizer M; Morsman AC; Cobben JM; van Roij MH; Elting MW; Verbeke JI; Wijnaendts LC; Shaw NJ; Högler W; McKeown C; Sistermans EA; Dalton A; Meijers-Heijboer H; Pals G
    Am J Hum Genet; 2009 Oct; 85(4):521-7. PubMed ID: 19781681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe osteogenesis imperfecta in cyclophilin B-deficient mice.
    Choi JW; Sutor SL; Lindquist L; Evans GL; Madden BJ; Bergen HR; Hefferan TE; Yaszemski MJ; Bram RJ
    PLoS Genet; 2009 Dec; 5(12):e1000750. PubMed ID: 19997487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel mutation in LEPRE1 that eliminates only the KDEL ER- retrieval sequence causes non-lethal osteogenesis imperfecta.
    Takagi M; Ishii T; Barnes AM; Weis M; Amano N; Tanaka M; Fukuzawa R; Nishimura G; Eyre DR; Marini JC; Hasegawa T
    PLoS One; 2012; 7(5):e36809. PubMed ID: 22615817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in PPIB (cyclophilin B) delay type I procollagen chain association and result in perinatal lethal to moderate osteogenesis imperfecta phenotypes.
    Pyott SM; Schwarze U; Christiansen HE; Pepin MG; Leistritz DF; Dineen R; Harris C; Burton BK; Angle B; Kim K; Sussman MD; Weis M; Eyre DR; Russell DW; McCarthy KJ; Steiner RD; Byers PH
    Hum Mol Genet; 2011 Apr; 20(8):1595-609. PubMed ID: 21282188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.
    Fratzl-Zelman N; Barnes AM; Weis M; Carter E; Hefferan TE; Perino G; Chang W; Smith PA; Roschger P; Klaushofer K; Glorieux FH; Eyre DR; Raggio C; Rauch F; Marini JC
    J Clin Endocrinol Metab; 2016 Sep; 101(9):3516-25. PubMed ID: 27383115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta.
    Baldridge D; Schwarze U; Morello R; Lennington J; Bertin TK; Pace JM; Pepin MG; Weis M; Eyre DR; Walsh J; Lambert D; Green A; Robinson H; Michelson M; Houge G; Lindman C; Martin J; Ward J; Lemyre E; Mitchell JJ; Krakow D; Rimoin DL; Cohn DH; Byers PH; Lee B
    Hum Mutat; 2008 Dec; 29(12):1435-42. PubMed ID: 18566967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deficiency of CRTAP in non-lethal recessive osteogenesis imperfecta reduces collagen deposition into matrix.
    Valli M; Barnes AM; Gallanti A; Cabral WA; Viglio S; Weis MA; Makareeva E; Eyre D; Leikin S; Antoniazzi F; Marini JC; Mottes M
    Clin Genet; 2012 Nov; 82(5):453-9. PubMed ID: 21955071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.